Is colorectal surveillance indicated in patients with PTEN mutations?

Nieuwenhuis, M.H.; Kets, C.M.; Murphy-Ryan, M.; Colas, C.; Moller, P.; Hes, F.J.; ... ; Vasen, H.F.A. (2012)

Article / Letter to editor

• PTEN phosphohydrolase
• multiple hamartoma syndrome
• colorectal neoplasms

• All authors: Nieuwenhuis, M.H.; Kets, C.M.; Murphy-Ryan, M.; Colas, C.; Moller, P.; Hes, F.J.; Hodgson, S.V.; Olderode-Berends, M.J.W.; Aretz, S.; Heinimann, K.; Gomez Garcia, E.B.; Douglas, F.; Spigelman, A.; Timshel, S.; Lindor, N.M.; Vasen, H.F.A.
• Date: 2012-09-30
• Volume: 14
• Issue: 9
• Pages: e562 - e566
• DOI: doi:10.1111/j.1463-1318.2012.03121.x